Federal Register of Legislation - Australian Government

Primary content

Specifications as made
The specification has the effect of specifying, for the purposes of paragraph 3(5)(ca) of the Act, advisory statements that are required to be set out on the label of medicines that are included in a class of medicines prescribed by the regulations.
Administered by: Health
Registered 02 Dec 2015
Tabling HistoryDate
Tabled HR03-Dec-2015
Tabled Senate02-Feb-2016
Date of repeal 01 Jul 2017
Repealed by Medicines Advisory Statements Specification 2017
Enabled by
Authoritative version Therapeutic Goods Act 1989
C2004A03952No. 21, 1990